Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAnpario Regulatory News (ANP)

Share Price Information for Anpario (ANP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 265.00
Bid: 260.00
Ask: 270.00
Change: 0.00 (0.00%)
Spread: 10.00 (3.846%)
Open: 265.00
High: 265.00
Low: 265.00
Prev. Close: 265.00
ANP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half-yearly Report

15 Sep 2010 07:00

KIOTECH INTERNATIONAL PLC (AIM: KIO)

("Kiotech" or "the Company")

Kiotech International plc, the international supplier of natural high performance feed additives to enhance growth, health and sustainability in agriculture and aquaculture, is pleased to announce its interim results for the 6 months to 30 June 2010.

Key points: Financial

Optivite, acquired in September 2009, makes a full six months contribution. 157% increase in profit before tax to £0.777m (2009: £0.302m). Threefold advance in sales to £11.082m (2009: £3.468m). Cash balance of £4.554m at 30 June 2010.

Key points: Operational

Integration of Optivite progressing well with consolidation of our operations starting to deliver the planned benefits. Good performance from our international agriculture division. Contracts exchanged to acquire the Manton Wood production and head office site for £1.450m. Aquatice® given approval to market for both fin fish and shrimp in the Philippines.

Richard Rose, Chairman, commented:

"We are encouraged by our trading performance to date and remain confident going forward given the good progress in integrating the Optivite acquisition. Management remains focused on consolidating our operations into a single unit to deliver the planned benefits, whilst retaining and promoting separate brands in the marketplace."

Enquiries:
Kiotech International plc
Richard Edwards, Chief Executive +44 (0)77 7641 7129
Karen Prior, Group Finance Director +44 (0)1909 478919
FinnCap +44 (0)20 7600 1658
Matthew Robinson / Henrik Persson - Corporate Finance
Stephen Norcross - Corporate Broking

KIOTECH INTERNATIONAL plcInterim results for 6 months to 30 June 2010

Chairman's Statement

I am delighted to report a strong performance in the period under review, boosted by good progress integrating last September's acquisition of Optivite. A great deal of work has been undertaken in consolidating our finance and operational activities into Optivite's main production site and office at Manton Wood. There are still a number of projects underway and we expect these to be completed by the end of this year.

Results

In the six months to 30 June 2010 profit before tax increased significantly to £0.777m (2009: £0.302m). Sales also advanced strongly to £11.082m (2009: £3.468m). This performance reflects continued organic growth and a full six months contribution from the Optivite acquisition.

Income tax expense has benefited from a credit of £0.128m resulting from favourable adjustments to prior year computations. On 3 September 2010 we exchanged contracts to acquire for £1.45m, a long leasehold interest in our head office and main manufacturing site at Manton Wood, Worksop, previously occupied on a short lease.

The balance sheet remains strong with good cash generation and the Company ended the period with a cash balance of £4.554m (30 June 2009: £1.780m; 31 December 2009: £5.015m).

Optivite integration

Our production activities have been consolidated into Optivite's modern feed additive plant at Manton Wood. This plant has now doubled its production throughput, with additional Agil volume and a strong performance from Optivite International, and we are starting to experience improved efficiencies. Further investment has been made to increase warehousing capacity, and we are currently extending the offices to accommodate staff transferred from Optivite's International team, who were located in offices nearby.

Optivite's UK business comprises higher margin functional feed additives but also lower margin fats and concentrates, some of which was unprofitable due to the very competitive nature of the fats business. Consolidating production will go some way to improve our margins in this product group. We have also improved our sales management structure in the UK by identifying and focusing on key market segments where we have a strong value proposition for the customer. These changes have also included recruiting a new sales team with responsibility for driving growth in these specific segments.

The integration is progressing well and we expect to have completed all major projects by the end of this year, and although we are beginning to experience some of the benefits of the integration it will inevitably be a while before the full impact is felt.

We have also taken the decision to close Optivite's North Scarle site at the end of the year, when we will transfer its fats and concentrates business to Manton Wood. These changes mean that our operations will now be focused on just two sites: Manton Wood for the functional feed additive business and Boroughbridge, in North Yorkshire, where Vitrition, our organic feed business is located. Manton Wood, which also contains the head office, is a strategic site for the Company hence the decision to buy the land and buildings to give security of tenure on which to make long term investment decisions.

Operations - Agriculture

Agil continued to make progress during the period with some particularly strong performances from Argentina, Bangladesh, Malaysia, Peru and Poland. In Malaysia we successfully launched a new mycotoxin binder product, called Neutox, which in addition to removing harmful mycotoxins in the animal feed also prevents future mould growth and consequently new toxin development. The success of this value-add product has encouraged us to market it in other territories around the world.

A number of strong performers last year have struggled to maintain their momentum in the first six months of this year for differing reasons. Chile's poultry integrators have been affected by the earthquake earlier this year, and Vietnam's aquaculture industry, into which we sold significant volumes of our pellet binder, Aquacube®, suffered a poor market towards the end of 2009. It is a feature of the business that being geographically diverse means short-term poor performance in a territory can be offset by strength elsewhere in the world.

We now have four acidifier products registered in Brazil, where our distributor is focusing on marketing Salkil to some of the world's largest poultry integrators, where feed volumes are significant. In China, we now have a number of products registered, for which we have embryonic sales. Again, our Chinese sales team is focusing on some of the larger meat producers where the volumes are significant but the selling process can be lengthy and sometimes complex.

Vitrition, our organic feed brand, which operates from one of only two dedicated organic feed mills in the UK, and accounts for around 17% of Group turnover, has been focused on improving margins in the business.

The Optivite acquisition brought a range of more nutritionally based products to our portfolio, which complement Agil's strength in products for biosecurity applications. The Agil sales team has started to market a number of these new products such as the omega-3 supplements, which Optivite developed and leads the market. These supplements enhance fertility, viability of young animals, growth rate and also increase the omega-3 content of meat and eggs for human consumption. Human health is an important consideration in household purchasing decisions around the world; especially as developing nations move towards a more meat protein based diet.

Operations - Aquaculture

We have a number of customer trials underway in Thailand for both Tilapia and Shrimp Aquatice®. Our Head of Aquaculture, based in Thailand, has set up and is overseeing these trials jointly with the farmers to ensure we learn as much as possible about the practicalities of farmers using Aquatice®. These trials will complete later in the year when the ponds are fully harvested, by which time the farmer will be able to evaluate the benefits of the product. We are also working with a number of partners in China and the Philippines and have recently been granted registration for Tilapia and Shrimp Aquatice® for the Philippines.

Board Membership

Mark Nicholls retired from the Board on 26 April 2010; the Board would like to record the Company's appreciation of his contribution to the development of Aquatice®. Richard Scragg, the founder and Chairman of Optivite, joined the Kiotech Board last October following the acquisition. Now that the integration is well established and proceeding according to plan, Richard will become a non-executive director of the Company with effect from 1 October 2010. I am delighted that the Company will continue to benefit from Richard's extensive knowledge and experience of our industry.

Outlook

We are encouraged by the trading performance so far this year. We are continuing to generate organic growth while also successfully further integrating the Optivite acquisition. Management is also working on new business development opportunities including territory expansion and product development, while also maintaining close links with Thai aquaculture farmers to demonstrate the benefits of Aquatice®.

We look forward with confidence backed by a strong balance sheet and cash position, which allows us to consider further acquisition opportunities to broaden our product and geographic spread and enhance shareholder value.

Richard S RoseChairman15 September 2010

Principal risks and uncertainties

The group set out in its 2009 Annual Report and Financial Statements the principal risks and uncertainties that could impact its performance; these remain unchanged since the annual report was published.

Unaudited consolidated income statement
For the six months ended 30 June 2010

Six months to

Six months to

Year ended

30.06.10 30.06.09 31.12.09
Note £000 £000 £000
Revenue 3 11,082 3,468 10,955
Cost of sales (8,193) (2,210) (7,823)
Gross profit 2,889 1,258 3,132
Administrative expenses (2,135) (980) (2,429)
Gains on sale of intellectual property - - 675
Operating profit 754 278 1,378
Interest receivable (net) 23 24 31
Profit before income tax 777 302 1,409
Income tax expense (105) (85) (194)
Profit for the period from continuing operations 672 217 1,215

Profit for the year attributable to:

Owners of the parent 660 217 1,211
Minority Interest 12 - 4
672 217 1,215
The consolidated income statement has been prepared on the basis that all operations are continuing operations.
Earnings per share attributable to the equity holders of the company:
Basic earnings per share (pence) 4 0.16 0.09 0.41
Diluted earnings per share (pence) 4 0.16 0.09 0.41
Unaudited consolidated statement of comprehensive income
For the six months ended 30 June 2010

Six months to

Six months to

Year ended

30.06.10 30.06.09 31.12.09
£000 £000 £000
Profit for the period 672 217 1,215
Currency translation differences - - 1
Total comprehensive income for the year 672 217 1,216
Attributable to:
Owners of the parent 660 217 1,212
Minority Interest 12 - 4
Total comprehensive income for the year 672 217 1,216
The above consolidated income statement should be read in conjunction with the accompanying notes.
Unaudited consolidated balance sheet
For the six months ended 30 June 2010
As at As at As at
30.06.10 30.06.09 31.12.09
Note £000 £000 £000
Non current assets
Intangible assets 5 6,829 4,363 6,773
Property, plant and equipment 877 367 662
7,706 4,730 7,435
Current assets
Inventories 1,217 432 1,291
Trade and other receivables 5,255 2,150 4,911
Cash and cash equivalents 4,554 1,780 5,015
11,026 4,362 11,217
Total Assets 18,732 9,092 18,652
Equity and Liabilities
Called up share capital 4,209 2,511 4,209
Share premium account 2,957 - 2,957
Other reserves 517 256 508
Special reserve 4,441 4,441 4,441
Retained earnings 2,105 451 1,445
14,229 7,659 13,560
Minority Interests 57 - 45
Total Equity 14,286 7,659 13,605
Non-current liabilities
Borrowings 13 - 30
Deferred Income tax liabilities 498 - 493
511 - 523
Current Liabilities
Trade and other payables 3,420 1,203 4,109
Corporation tax 515 230 415
3,935 1,433 4,524
Total Liabilities 4,446 1,433 5,047
Total Equity and Liabilities 18,732 9,092 18,652
The above consolidated balance sheet should be read in conjunction with the accompanying notes.
Unaudited consolidated statement of cashflows
For the year ended 30 June 2010
Six months to Six months to Year ended
30.06.10 30.06.09 31.12.09
£000 £000 £000
Cash generated from operating activities (154) 31 2,421
Interest paid - - (1)
Income tax paid - 14 (340)
Net cash generated from operating activities (154) 45 2,080
Cash generated from investing activities
Acquisition of subsidiary net of cash acquired - - (3,127)
Payments to acquire intangible fixed assets (67) (141) (226)
Purchases of plant and equipment (254) (15) (44)
Proceeds from disposals of plant and equipment 8 - -
Interest received 23 24 31
Net cash used in investing activities (290) (132) (3,366)
Cashflows from financing activities
Proceeds from issuance of shares - - 4,541
Dividend paid to Company's shareholders - - (101)
Repayment of borrowings (17) - (7)
Net cash used in financing activities (17) - 4,433
Net (decrease)/increase in cash and cash equivalents (461) (87) 3,147
Cash and cash equivalents at the beginning of the period 5,015 1,867 1,868
Cash and cash equivalents at the end of the period 4,554 1,780 5,015
Six months to Six months to Year ended
30.06.10 30.06.09 31.12.09
£000 £000 £000
Profit before income tax 777 302 1,409
Adjustments for:
Finance costs (23) (24) (31)
Depreciation and amortisation 50 65 82
Profit on disposal of plant and equipment (8) - -
Share based payments 9 7 30
Changes in working capital:
Inventories 74 37 (183)
Trade and other receivables (344) (455) 350
Trade and other payables (689) 99 764
Cash generated from operations (154) 31 2,421
The above consolidated statement of cashflows should be read in conjunction with the accompanying notes.
Unaudited consolidated statement of changes in equity
for the period ended 30 June 2010
Attributable to the owners Share Share Special Other Retained Minority Total
of the parent Capital Premium Reserve Reserves Earnings Interests Equity
£000 £000 £000 £000 £000 £000 £000
Balance at 1 January 2009 2,511 - 4,441 249 335 - 7,536
Profit - - - - 217 217
Total comprehensive income for the half year - - - - 217 - 217
Transactions with owners
Share based payment adjustments - - 7 - - 7
Dividends relating to 2008 - - - (101) - (101)
Transactions with owners - - - 7 (101) - (94)
Balance at 30 June 2009 2,511 - 4,441 256 451 - 7,659
Profit - - - - 994 4 998
Total comprehensive income for the year - - - - 994 4 998
Transactions with owners
Issue of shares 1,698 2,957 - 229 - - 4,884
Share based payment adjustments - - - 23 - - 23
Transactions with owners 1,698 2,957 - 252 - - 4,907
Minority interests arising - - - - - 41 41
Balance at 1 January 2010 4,209 2,957 4,441 508 1,445 45 13,605
Profit - - - - 660 12 672
Total comprehensive income for the half year - - - - 660 12 672
Transactions with owners
Share based payment adjustments - - - 9 - - 9
Transactions with owners - - - 9 - - 9
Minority interests arising - - - - - - -
Balance at 30 June 2010 4,209 2,957 4,441 517 2,105 57 14,286
The above consolidated statement of changes in equity should be read in conjunction with the accompanying notes.

Notes to the financial statements

1. General information KiotechInternational plc ("the company") and its subsidiaries (together "the group") manufacture and supply products to enhance the health, growth and sustainability in agriculture and aquaculture.

The company acquired the Optivite Group on 30 September 2009.The company is traded on the London Stock Exchange Aim market and is incorporated and domiciled in the UK. The address of the registered office is Unit 5 Manton Wood Enterprise Park, Worksop, Nottinghamshire, S80 2RS.

2. Basis of preparationThe consolidated interim financial statements comprise the accounts of the company and its subsidiaries drawn up to 30 June 2010.

The consolidated interim financial statements have been prepared on the basis of the accounting policies set out in the group's annual financial statements for the year ended 31 December 2009, which are available on the company's web site at www.kiotech.com.

Of the new standards, amendments and interpretations that are in issue and mandatory for the financial year end to 31 December 2010, there is no financial impact on these consolidated interim financial statements.

This condensed consolidated interim financial information does not comprise statutory accounts within the meaning of section 434 of the Companies Act 2006. Statutory accounts for the year ended 31 December 2009 were approved by the Board of Directors on 25 May 2010 and delivered to the Registrar of companies. The report of the auditors on those accounts was unqualified, did not contain an emphasis of matter paragraph and did not contain any statement under section 498 of the Companies Act 2006.

The consolidated interim financial information for the period ended 30 June 2010 is unaudited.

3. Segment informationAll revenues from external customers are derived from the sale of goods in the ordinary course of business to the agricultural and aquacultural markets and are measured in a manner consistent with that in the income statement.

Management has determined the operating segments based on the reports reviewed by the Board that are used to make strategic decisions. The Board considers the business from a geographic perspective.

Management considers adjusted EBITDA, which comprises Earnings before interest, tax , depreciation and amortisation adjusted for share-based payments.

UK and Eire

International Total
£000 £000 £000
Half year 2010
Total segmental revenue 5,098 6,076 11,174
Inter-segment revenue - (92) (92)
Revenue from external customers 5,098 5,984 11,082
Adjusted EBITDA 187 626 813
Depreciation and amortisation 25 25 50
Income tax (credit)/expense 52 (157) (105)
Total assets 4,444 14,288 18,732
Total liabilities (2,095) (2,351) (4,446)
Half year 2009
Total segmental revenue 204 3,264 3,468
Inter-segment revenue - - -
Revenue from external customers 204 3,264 3,468
Adjusted EBITDA 20 330 350
Depreciation and amortisation - 65 65
Income tax expense (6) (79) (85)
Total assets 34 9,058 9,092
Total liabilities (6) (1,427) (1,433)
Year ended 31 December 2009
Total segmental revenue 3,762 7,644 11,406
Inter-segment revenue (440) (11) (451)
Revenue from external customers 3,322 7,633 10,955
Adjusted EBITDA 95 1,395 1,490
Depreciation and amortisation 59 23 82
Income tax expense (12) (181) (193)
Total assets 3,665 14,987 18,652
Total liabilities (2,438) (2,609) (5,047)
A reconciliation of adjusted EBITDA to profit before tax is provided as follows:
Six months to Six months to Year ended
30.06.10 30.06.09 31.12.09
£000 £000 £000
Adjusted EBITDA for reportable segments 813 350 1,490
Depreciation, amortisation and impairment provisions (50) (65) (82)
Share-based payment charges (9) (7) (30)
Finance income-net 23 24 31
Profit before tax 777 302 1,409
4. Earnings per share Six months to Six months to Year ended
30.06.10 30.06.09 31.12.09
Weighted average number of shares in issue (000's) 420,899 251,079 293,534
Fully diluted weighted average number of shares in issue (000's) 424,695 252,129 298,367
Profit attributable to equity holders of the company (£000's) 660 217 1,211
Basic earnings per share (pence) 0.16 0.09 0.41
Gains on sale of intellectual property (pence per share) - - (0.21)
Underlying earnings per share 0.16 0.09 0.20
Diluted earnings per share 0.16 0.09 0.41
5. Intangible fixed assets Goodwill, brands & Patents &
Customer relationships Developments Total
£000 £000 £000
Cost at 1 January 2010 5,822 1,083 6,905
Additions - 67 67
Cost at 30 June 2010 5,822 1,150 6,972
Amortisation at 1 January 2010 - 132 132
Charge for the period 10 1 11
Amortisation at 30 June 2010 10 133 143
Net book value at 30 June 2010 5,812 1,017 6,829
Net book value at 1 January 2010 5,822 951 6,773

Copyright Business Wire 2010

Date   Source Headline
21st Mar 202411:37 amRNSDirector/PDMR Shareholding
21st Mar 20247:00 amRNSDirector/PDMR Shareholding
5th Feb 20247:00 amRNSAward of Options and Director/PDMR Shareholding
24th Jan 20247:00 amRNSFull year trading statement
17th Jan 20247:00 amRNSBlock listing Interim Review
5th Oct 20239:23 amRNSDirector Disclosure
13th Sep 20237:00 amRNSHalf-year Report
25th Aug 20235:10 pmRNSBlock listing Interim Review
1st Aug 20237:00 amRNSDirectorate Change
10th Jul 20232:14 pmRNSHolding(s) in Company
7th Jul 20232:34 pmRNSHolding(s) in Company
29th Jun 20233:57 pmRNSResult of AGM
29th Jun 20237:00 amRNSAGM Statement
23rd Jun 20237:00 amRNSResult of Tender Offer
19th Jun 20232:48 pmRNSGM Statement
15th Jun 20237:00 amRNSShareholder Tour
7th Jun 20234:09 pmRNSReplacement - Tender Offer
6th Jun 20237:00 amRNSPosting of Annual Report and Notice of AGM
2nd Jun 20237:00 amRNSTender Offer
23rd May 20237:00 amRNSChange of Adviser
19th May 20234:40 pmRNSDirector Disclosures
19th May 20233:35 pmRNSTotal Voting Rights
5th May 20237:00 amRNSDirectorate Change
21st Apr 20237:00 amRNSAnpario receives King’s Award for Enterprise
11th Apr 20237:00 amRNSDirector/PDMR Shareholding
31st Mar 20231:13 pmRNSHolding(s) in Company
28th Mar 20237:00 amRNSDirector/PDMR Shareholding
22nd Mar 20237:00 amRNSFinal Results
3rd Feb 20237:00 amRNSDirector/PDMR Shareholding
24th Jan 202312:56 pmRNSBlock listing Interim Review
9th Jan 20237:00 amRNSFull Year Trading Statement
16th Dec 20227:00 amRNSAnpario receives ISO 14001 Certification
4th Nov 202212:52 pmRNSTotal Voting Rights
19th Oct 20227:00 amRNSDirector/PDMR Shareholding - Replacement
18th Oct 20227:00 amRNSDirector/PDMR Shareholding
6th Oct 20227:00 amRNSESG Initiatives
3rd Oct 20222:32 pmRNSDirector/PDMR Shareholding
14th Sep 20227:00 amRNSHalf-year Report
5th Sep 202212:38 pmRNSTotal Voting Rights
5th Aug 20222:00 pmRNSBob The Pigeon Back Home in Gateshead, Pet!
20th Jul 20221:02 pmRNSBlock listing Interim Review
7th Jul 20222:59 pmRNSHolding(s) in Company
22nd Jun 202211:24 amRNSAGM Statement
16th Jun 20226:00 pmRNSResult of AGM
16th Jun 20227:00 amRNSAGM Statement
27th May 202212:56 pmRNSHolding(s) in Company
24th May 20221:10 pmRNSHolding(s) in Company
11th May 20227:00 amRNSNotice of AGM
10th May 20223:55 pmRNSHolding(s) in Company
5th May 20223:18 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.